Does fingolimod in multiple sclerosis patients cause macular edema?

Journal of Neurology

Volumn 259, Issue 2, 2012, Pages 386-388

  Turaka, Kiran ^a   Bryan, Joseph Shepard ^a  

^a Associated Retina Consultants Ltd   (United States)

Author keywords

Fingolimod; Macular edema; Multiple sclerosis

Indexed keywords

FINGOLIMOD; PREDNISOLONE ACETATE;

ADULT; CASE REPORT; DRUG WITHDRAWAL; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA EDEMA; REVIEW; VISUAL ACUITY; VISUAL IMPAIRMENT;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACULAR EDEMA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROPYLENE GLYCOLS; SPHINGOSINE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84856698440     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6367-4     Document Type: Review

References (9)

1. J Derwenskus 2011 Current disease-modifying treatment of multiple sclerosis Mt Sinai J Med 78 161 175 21425262 10.1002/msj.20239
2. Huggins A, Sergott RC (2011) Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: with special emphasis upon visual safety. Curr Opin Ophthalmol Sep 22. [Epub ahead of print]
3. G Comi P O'Connor X Montalban J Antel EW Radue G Karlsson H Pohlmann S Aradhye L Kappos FTY720D2201 Study Group 2010 Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results Mult Scler 16 197 207 20028707 10.1177/1352458509357065 1:CAS:528:DC%2BC3cXjvFCqu7c%3D
4. [No authors listed] (2009) Trial watch: Phase III promise for oral multiple sclerosis therapy Nat Rev Drug Discov 8:98
5. J Chun V Brinkmann 2011 A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya) Discov Med 12 213 228 21955849
6. EA Yeh B Weinstock-Guttman 2011 Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis Adv Ther 28 270 278 21394595 10.1007/s12325-011-0004-6 1:CAS:528:DC%2BC3MXntVygtrc%3D
7. G Saab A Almony KJ Blinder R Schuessler DC Brennan 2008 Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient Arch Ophthalmol 126 140 141 18195237 10.1001/archophthalmol.2007.23
8. J Chun HP Hartung 2010 Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis Clin Neuropharmacol 33 91 101 20061941 10.1097/WNF. 0b013e3181cbf825 1:CAS:528:DC%2BC3cXksFSgt7g%3D
9. L Kappos EW Radue P O'Connor for the FREEDOMS Study Group 2010 A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 387 401 20089952 10.1056/NEJMoa0909494 1:CAS:528: DC%2BC3cXhvVWltr4%3D